Latest market price
66.28
-4.04-5.75%
OverviewShort InterestFilings
MNPRQT24Monopar Therapeutics Inc.·NASDAQ
66.28-5.75%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 20, 20264Statement of changes in beneficial ownership
Oct 05, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 28, 20264Statement of changes in beneficial ownership
Aug 28, 20264/AStatement of changes in beneficial ownership (amended)
Aug 28, 20264/AStatement of changes in beneficial ownership (amended)
Aug 27, 20264Statement of changes in beneficial ownership
Aug 27, 20264Statement of changes in beneficial ownership
Aug 27, 20264Statement of changes in beneficial ownership
Aug 12, 20268-KCurrent report
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 202610-QQuarterly report
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 20268-KCurrent report
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 2026S-8Registration of employee benefit securities
Jul 22, 2026S-8 POSS-8 POS
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 363
Page
▼
/ 15